Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells

Miao Sun1, Gary D Isaacs, Nasun Hah

  • 1Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8511, USA.

Insights

Estrogen and c-Jun N-terminal kinase 1 (JNK1) signaling pathways converge at the genome in breast cancer cells. This interaction, regulated by estrogen receptor alpha (ERα), influences gene expression and cell growth, impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Biology

Background:

  • Steroid hormone and MAPK signaling pathways are known to intersect.
  • The precise molecular mechanisms underlying this cross-talk, particularly between estrogen and JNK1, remain largely undefined.

Purpose of the Study:

  • To elucidate the genomic convergence of estrogen receptor alpha (ERα) and c-Jun N-terminal kinase 1 (JNK1) signaling pathways in breast cancer cells.
  • To investigate the functional consequences of this ERα-JNK1 interplay on gene expression and cell proliferation.

Main Methods:

  • Genome-wide analysis of JNK1 binding sites in breast cancer cells.
  • Chromatin immunoprecipitation (ChIP) assays to determine ERα and JNK1 occupancy at target promoters.
  • Kinase activity assays for JNK1.
  • Analysis of gene expression profiles and breast cancer patient data.

Main Results:

  • JNK1 binds to numerous genomic promoters, with a subset being estrogen-regulated.
  • ERα is essential for JNK1 recruitment to specific DNA elements, often involving activating protein-1.
  • JNK1 acts as a kinase-dependent transcriptional coregulator of ERα at target promoters.
  • This convergence regulates estrogen-dependent gene expression and cell growth.

Conclusions:

  • Estrogen and JNK1 signaling pathways functionally converge at the genomic level in breast cancer.
  • The interplay between ERα and JNK1 influences estrogen-driven gene expression and cell proliferation.
  • This ERα-JNK1 functional interplay may play a significant role in breast cancer progression and clinical outcomes.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...